Amelo Wote, Nagpal Pushpa, Makonnen Eyassu
School of Pharmacy, Jimma University, Jimma, Ethiopia.
BMC Complement Altern Med. 2014 Dec 3;14:462. doi: 10.1186/1472-6882-14-462.
Malaria is one of the most important infectious diseases in the World. The choice for the treatment is highly limited, and several of these may eventually be lost or compromised due to drug resistance. The use of plant medicine in the treatment of malaria and its various presentations is a common practice in many countries of Africa where the disease is mostly endemic. Dodonaea angustifolia is traditionally used in Ethiopia for prophylaxis against malaria. The present study is attempted to evaluate the antimalarial activity of the solvent fractions of root extracts of D. angustifolia in P. berghei infected mice.
In this study, 4-days Peter's suppressive test was used to determine parasite inhibition. Acute toxicity test was also conducted on the most active fraction according to Organization for Economic Cooperation and Development (OECD) guidelines 425. Data was analyzed by using Windows SPSS version 16 and expressed as mean ± SD for each dose level. ANOVA followed by Post Hoc Tukey's HSD was used to compare result between treatment and control groups. Students paired t-test was employed to test significance for the difference between initial and final results within the same group.
All three fractions showed varying degrees of antiplasmodial activity. The n-butanol fraction displayed a relatively highest suppression of parasitaemia (67.51%) at an oral dose of 600 mg/kg. Lower doses, 200 mg/kg and 400 mg/kg, of the fraction also resulted in parasitaemia suppression of 38.02% and 55.85%, respectively. Chemosuppressive activity of chloroform and aqueous fractions was less compared to that of n-butanol fraction. All the three fractions displayed dose dependent significant (P < 0.001) antiplasmodial activity as compared to the control. Survival time was prolonged in case of n-butanol and chloroform fractions. No lethality to mice was seen with n-butanol fraction up to a dose of 2000 mg/kg.
All the three fractions possessed significant antiplasmodial activity as compared with the control group. n-butanol fraction was found to be the most active fraction with minimal toxicity and might contain potential lead molecule for the development of a new drug for treatment of malaria.
疟疾是世界上最重要的传染病之一。治疗选择非常有限,其中几种最终可能因耐药性而失效或受到影响。在许多疟疾流行的非洲国家,使用植物药治疗疟疾及其各种症状是一种常见做法。埃塞俄比亚传统上使用狭叶车桑子预防疟疾。本研究旨在评估狭叶车桑子根提取物的溶剂部分对感染伯氏疟原虫的小鼠的抗疟活性。
在本研究中,采用4天的彼得氏抑制试验来确定寄生虫抑制情况。还根据经济合作与发展组织(OECD)指南425对活性最高的部分进行了急性毒性试验。使用Windows SPSS 16版分析数据,并以每个剂量水平的平均值±标准差表示。采用方差分析(ANOVA),随后进行事后检验Tukey's HSD,以比较治疗组和对照组之间的结果。采用学生配对t检验来检验同一组内初始结果和最终结果之间差异的显著性。
所有三个部分均表现出不同程度的抗疟原虫活性。正丁醇部分在口服剂量为600 mg/kg时表现出相对最高的疟原虫血症抑制率(67.51%)。该部分较低剂量200 mg/kg和400 mg/kg也分别导致疟原虫血症抑制率为38.02%和55.85%。氯仿部分和水部分的化学抑制活性低于正丁醇部分。与对照组相比,所有三个部分均表现出剂量依赖性显著(P < 0.001)的抗疟原虫活性。正丁醇部分和氯仿部分的存活时间延长。正丁醇部分在剂量高达2000 mg/kg时未观察到对小鼠的致死性。
与对照组相比,所有三个部分均具有显著的抗疟原虫活性。发现正丁醇部分是活性最高的部分,毒性最小,可能含有用于开发治疗疟疾新药的潜在先导分子。